Ophthalmology · Miami, FL
NPI
1649267592
Since 2005
Specialty
Ophthalmology
Code 207W00000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
401 SW 27th Ave
Miami, FL, 33135
Phone (305) 541-6606
Groups this clinician bills Medicare through
Medicare paid, 2024
$46K
396 services
Medicare patients, 2024
151
Average age 78
Drug cost, 2024
$1.1M
8,490 prescriptions
Company payments, 2025
$682
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Orlando A Galindez was code 92014 (ophthalmological e&m), 78 times for 70 patients. In total Orlando A Galindez billed 396 services in 22 codes, and Medicare paid $46K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-01-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92014 Ophthalmological E&M | Office | 78 | 70 | $96.69 | $7,541 |
| 92250 Angiography | Office | 62 | 60 | $28.98 | $1,797 |
| 92012 Ophthalmological E&M | Office | 52 | 44 | $68.46 | $3,560 |
| 66984 Cataract Surgery | Facility | 45 | 32 | $446.27 | $20K |
| 92134 Computerized Ophthalmic Imaging | Office | 36 | 33 | $29.39 | $1,058 |
| 92083 Vision, Hearing, and Speech Services | Office | 36 | 34 | $50.43 | $1,815 |
| 92136 Ultrasound - Nonspecific | Office | 36 | 34 | $31.55 | $1,136 |
| 99204 Office E&M - New | Office | 22 | 22 | $141.20 | $3,106 |
By year: 2022 $102K for 897 services; 2023 $68K for 499 services; 2024 $46K for 396 services.
Medicare prescription drug claims, 2024
In 2024, the drug Orlando A Galindez prescribed most often to Medicare patients was Prednisolone Acetate, with 2,231 prescriptions and refills. In total Orlando A Galindez wrote 8,490 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisolone Acetate Generic | 2,231 | 2,347 | 1,018 | $57K |
| Moxifloxacin Moxifloxacin Hcl | 1,362 | 1,370 | 651 | $60K |
| Latanoprost Generic | 1,136 | 1,706 | 292 | $5,164 |
| Brimonidine Tartrate Generic | 465 | 624 | 121 | $21K |
| Timolol Maleate Generic | 428 | 682 | 101 | $6,245 |
| Lumigan Bimatoprost | 313 | 429 | 73 | $112K |
| Brimonidine Tartrate-Timolol Brimonidine Tartrate/Timolol | 262 | 358 | 68 | $24K |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 236 | 396 | 64 | $1,677 |
| Restasis Cyclosporine | 229 | 313 | 80 | $185K |
| Xiidra Lifitegrast | 164 | 166 | 40 | $114K |
| Combigan Brimonidine Tartrate/Timolol | 156 | 192 | 35 | $40K |
| Vyzulta Latanoprostene Bunod | 148 | 173 | 26 | $44K |
| Dorzolamide Hcl Generic | 109 | 187 | 41 | $1,596 |
| Simbrinza Brinzolamide/Brimonidine Tart | 95 | 114 | 20 | $20K |
| Ilevro Nepafenac | 85 | 117 | 35 | $33K |
Brand drugs: 4,352 claims; generic drugs: 4,138 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Orlando A Galindez $682 ($682 in general payments such as food, travel and fees) from 10 companies. The largest payer was Mallinckrodt Hospital Products Inc. with $187.
| Company | Payments | Amount |
|---|---|---|
| Mallinckrodt Hospital Products Inc. | 9 | $187 |
| Abbvie Inc. ABBV | 5 | $113 |
| Alcon Vision LLC ALC | 4 | $94.45 |
| Biotissue Holdings Inc. | 1 | $78.09 |
| Bausch & Lomb Americas Inc. BLCO | 4 | $77.17 |
| Amgen Inc. AMGN | 1 | $32.97 |
| New World Medical,Inc. | 3 | $27.19 |
| Tarsus Pharmaceuticals, Inc. TARS | 1 | $24.55 |
| Oyster Point Pharma, Inc. | 1 | $24.49 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 1 | $23.06 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.